Newly described bone collector caterpillars build a silken case around their bodies and adorn it with dead insect body parts ...

Spider-Man franchise star Tony Revolori opens up about his future in the Marvel Cinematic Universe as Flash Thompson.

Spider-Man: Beyond the Spider-Verse will be released in theaters on June 4, 2027, Sony Pictures announced at their CinemaCon presentation Monday. The first photos from the highly anticipated movie ...

EXCLUSIVE: Cameras have started rolling on Spider Island, an original comedy-horror from UK indie Vertigo Films. The project is shooting on location in Mauritius. The film follows a group of ...

Border Patrol officers in Texas arrested two U.S. citizens after a spider monkey was found hidden inside a backpack. The spider monkey was taken to the Gladys Porter Zoo in Brownsville, Texas. The ...

Inpex has commenced the front-end engineering and design phase for the so-called onshore LNG (OLNG) scope for its multibillion-dollar 9.5 million tonnes per annum Abadi liquefied natural gas ...

NEW DELHI: ITI Limited has opened the State Network Operations Center (S-NOC) of the BharatNet Phase-III project at Solan in Himachal Pradesh in coordination with the state-run telecom operator ...

The selection process includes three stages Phase 1, Phase 2, and Interview. Phase 1 is an objective test, while Phase 2 includes both objective and descriptive papers. Knowing the syllabus helps ...

Check out the cover artwork to Spider-Man vs. The Sinister Sixteen by Terry and Rachel Dodson, as well as a first look at Phil Noto’s interior artwork… Peter Parker was just trying to have a ...

Jos Fernandez, CEO and Art Director of Ironhead Studio, was one of the technicians. He has worked on Spider-Man: Homecoming, Captain America: Civil War, and Avengers: Age of Ultron. James Madigan, VFX ...

Despite several arrests last year, Scattered Spider's social engineering attacks are continuing ... suggesting this malware is still in a heavy developmental phase. We expect the malware to evolve ...

Racing toward a $1.6 billion market, the biotech stopped work on RLYB212 in a rare maternal immune disorder in response to phase 2 data. RLYB212, an anti-HPA-1a antibody, was in phase 2 ...